FDA Inspection 967278 — Prinston Pharmaceutical Inc.
The FDA completed an inspection of Prinston Pharmaceutical Inc. on Apr 5, 2016 in Somerset, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 5, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Somerset, NJ (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)